Key result
Traditional Chinese medicine shows potential CVD prevention benefits, but robust hard-outcome trials remain lacking.
Why the study?
The explicit role of traditional Chinese medicine in preventing and treating cardiovascular disease remains unclear due to a lack of sound scientific evidence and flawed randomized controlled trials.
Does Traditional Chinese medicine improve outcomes in patients with cardiovascular disease?
Systematic Review
Does Traditional Chinese medicine improve outcomes in patients with cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Traditional Chinese medicine may serve as a complementary approach for cardiovascular disease prevention, but high-quality randomized controlled trials are needed to confirm long-term benefits.
Traditional Chinese medicine (TCM) has more than 2,000 years of history and has gained widespread clinical applications. However, the explicit role of TCM in preventing and treating cardiovascular disease remains unclear due to a lack of sound scientific evidence. Currently available randomized controlled trials on TCM are flawed, with small sample sizes and diverse outcomes, making it difficult to draw definite conclusions about the actual benefits and harms of TCM. Here, we systematically assessed the efficacy and safety of TCM for cardiovascular disease, as well as the pharmacological effects of active TCM ingredients on the cardiovascular system and potential mechanisms. Results indicate that TCM might be used as a complementary and alternative approach to the primary and secondary prevention of cardiovascular disease. However, further rigorously designed randomized controlled trials are warranted to assess the effect of TCM on long-term hard endpoints in patients with cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2017) conducted a systematic review in Cardiovascular disease. Traditional Chinese Medicine (TCM) was evaluated. Traditional Chinese medicine might be used as a complementary approach for preventing cardiovascular disease, though current evidence lacks rigorous trials assessing long-term hard endpoints.
Synapse has enriched 10 related papers. Consider them for comparative context: